article thumbnail

How Chemotherapy Drug Shortages Impact Patient Care

Pharmacy Times

Drug shortages are a common issue in the health care industry. Florida Cancer Specialists & Research Institute (FCS) is highly skilled at proactively managing the drug supplies it needs to care for patients.

article thumbnail

STAT+: FDA alters warning label for Carvykti CAR-T, although link to secondary cancers is unclear

STAT

“I do not believe this particular change will have any bearing on patient care,” said Saad Usmani, a myeloma physician and cell therapist at Memorial Sloan Kettering who has also studied Carvykti.

Labelling 127
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is Infusion Pharmacy Right For You?

The Happy PharmD

Infusion pharmacy, also known as home care or specialty pharmacy, encompasses a variety of crucial medical services. From chemotherapy to nutrition support and infectious disease treatments, infusion pharmacists play a vital role in delivering specialized care directly to patients.

article thumbnail

Enhancing collaboration to optimise medication therapy in older adults with cancer: a position paper from SOFOG-SFPO

Hospital Pharmacy Europe

In this heterogeneous patient group, decisions on therapies and management must follow a multidimensional approach, integrating medical, socio-economic and psychological factors. Drug classes known to cause falls are commonly used in older patients , but cancer treatment can further increase this risk.

article thumbnail

FDA approves AbbVie-Genmab’s Epkinly to treat DLBCL

Pharmaceutical Technology

“The FDA approval of Epkinly represents a new treatment mechanism of action for third-line DLBCL patients. “As As a non-chemotherapy, single-agent treatment for DLBCL patients, we hope that Epkinly can effectively treat this aggressive cancer type and can be used for patient care quickly and in an off-the-shelf form for physicians.

FDA 52
article thumbnail

Integrating personalised colorectal cancer vaccines into the evolving treatment landscape

Hospital Pharmacy Europe

With an introduction from Helena Beer, Dr Kunene shares first-hand insights into the clinical trial, the NHS Cancer Vaccine Launch Pad initiative and their potential for revolutionising patient care. Another treatment combination is chemotherapy with zolbetuximab – an antibody directed against claudin 18.6.

article thumbnail

The changing treatment landscape of acute lymphoblastic leukaemia

Hospital Pharmacy Europe

The CAR T-cell therapy tisagenlecleucel has recently been given the green light for routine rollout on the NHS to treat paediatric patients with acute lymphoblastic leukaemia. These patients often reach the ceiling for toxicity in terms of chemotherapy and radiotherapy in the context of a bone marrow transplant.